ethinyl estradiol has been researched along with 9,10-dimethyl-1,2-benzanthracene in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asselin, J; Caron, MG; Kelly, PA; Labrie, F; Raynaud, JP | 2 |
| Asselin, J; Kelly, PA; Labrie, F; Raynaud, JP | 1 |
| Lemon, HM | 1 |
| Holtzman, S | 1 |
| Feenstra, A; Nolten, GM; Reiffers, S; Vaalburg, W; Woldring, MG | 1 |
| Imaida, K; Ito, N; Iwasaki, S; Kato, T; Masui, T; Mori, T; Shirai, T | 1 |
| Cho, YM; Hasumura, M; Hirose, M; Imai, T; Onose, J; Ueda, M | 1 |
| Bouker, KB; Clarke, R; Cook, KL; Cruz, MI; de Assis, S; Hilakivi-Clarke, L; Hu, R; Jin, L; Nguyen, N; Wang, X; Wang, Y; Wärri, A; Wehrenberg, B; Xuan, J; Zhang, X; Zwart, A | 1 |
9 other study(ies) available for ethinyl estradiol and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Benz(a)Anthracenes; Estradiol; Estrogen Antagonists; Ethinyl Estradiol; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Ovary; Prolactin; Rats; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone | 1977 |
Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Estrogen Antagonists; Ethinyl Estradiol; Female; Mammary Neoplasms, Experimental; Ovary; Rats; Receptors, Steroid | 1977 |
Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Binding, Competitive; Estradiol; Estrogen Antagonists; Ethinyl Estradiol; Female; Mammary Neoplasms, Experimental; Ovary; Progesterone Congeners; Prolactin; Rats; Receptors, Estrogen; Receptors, Progesterone | 1976 |
Antimammary carcinogenic activity of 17-alpha-ethinyl estriol.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Ethinyl Estradiol; Female; Mammary Neoplasms, Experimental; Rats; Time Factors | 1987 |
Retinyl acetate inhibits estrogen-induced mammary carcinogenesis in female ACI rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Diterpenes; Eating; Ethinyl Estradiol; Female; Mammary Neoplasms, Experimental; Neoplasms, Multiple Primary; Rats; Rats, Inbred ACI; Retinyl Esters; Vitamin A | 1988 |
Radiotracers binding to estrogen receptors: I: Tissue distribution of 17 alpha-ethynylestradiol and moxestrol in normal and tumor-bearing rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carbon Radioisotopes; Estradiol Congeners; Estrus; Ethinyl Estradiol; Female; Mammary Neoplasms, Experimental; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Estrogen; Tissue Distribution; Uterus | 1982 |
Effects of testosterone, dihydrotestosterone and estrogen on 3,2'-dimethyl-4-aminobiphenyl-induced rat prostate carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Dihydrotestosterone; Ethinyl Estradiol; Male; Organ Size; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testosterone | 1994 |
Lack of prepubertal administration of ethinyl estradiol on susceptibility to multiple organ carcinogenesis in rats exposed to 7,12-dimethylbenz[a]anthracene and N-bis(2-hydroxypropyl)nitrosamine during adolescence.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Age Factors; Animals; Disease Susceptibility; Ethinyl Estradiol; Female; Male; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Nitrosamines; Rats; Rats, Inbred F344 | 2005 |
Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenovirus E1A Proteins; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; DNA Methylation; Drug Resistance, Neoplasm; Ethinyl Estradiol; Female; Galectin 3; Gene Expression; Gene Silencing; Histocompatibility Antigens Class I; Humans; Hydralazine; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Mammary Neoplasms, Experimental; Neoplasm Recurrence, Local; Pregnancy; Prenatal Exposure Delayed Effects; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ets; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tamoxifen; Trans-Activators; Valproic Acid | 2017 |